Drugs / Peptide pulsed Dendritic cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04879888 | Aug → Dec 2016 | female breast carcinoma | National University of Colombia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peptide pulsed Dendritic cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04879888 ↗ |
| Action | Deplete | “leading to the efficient destruction of the tumor by anti-tumor CD8 + T lymphocytes” NCT04879888 ↗ |
| Modality | Cell therapy | “autologous dendritic cells” NCT04879888 ↗ |